<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04206774</url>
  </required_header>
  <id_info>
    <org_study_id>HS066</org_study_id>
    <nct_id>NCT04206774</nct_id>
  </id_info>
  <brief_title>BIO|STREAM.ICM France</brief_title>
  <official_title>BIO|STREAM.ICM France, Submodule of the BIO|STREAM.ICM Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the BIO│STREAM.ICM France submodule is to provide clinical evidence
      from patients in France on safety and efficacy of the BIOMONITOR system
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The BIO|STREAM.ICM submodule will recruit a subset of patients with syncope with uncertain
      origin and cryptogenic stroke without history of atrial arrhythmia from the existing
      population enrolled in the BIO|STREAM.ICM registry. The submodule study is designed to
      provide clinical evidence from patients in France on safety and efficacy of the BIOMONITOR
      System.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 13, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SADE free rate</measure>
    <time_frame>3 month</time_frame>
    <description>Serious adverse device effect (SADE) free rate related to the BIOMONITOR system</description>
  </primary_outcome>
  <other_outcome>
    <measure>R-wave amplitude</measure>
    <time_frame>3 month</time_frame>
    <description>Assessment of R-wave Amplitude (Millivolt) detected by the BIOMONITOR and transmitted via Home Monitoring</description>
  </other_outcome>
  <other_outcome>
    <measure>Noise burden</measure>
    <time_frame>3 month</time_frame>
    <description>Assessment of electrical noise burden (%) detected by the BIOMONITOR and transmitted via Home Monitoring</description>
  </other_outcome>
  <other_outcome>
    <measure>Ventricular rate</measure>
    <time_frame>3 month</time_frame>
    <description>Assessment of mean ventricular rate (bpm) detected by the BIOMONITOR and transmitted via Home Monitoring</description>
  </other_outcome>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Syncope</condition>
  <condition>Cryptogenic Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated in French investigation sites, with an indication for Insertable Cardiac
        Monitors (ICM) in accordance with the European guidelines and followed with the BIOTRONIK
        Home Monitoring® system.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for ICM device in accordance with the European guidelines: syncope with
             uncertain origin or cryptogenic stroke without history of atrial arrhythmia

          -  Enrolled in the BIO|STREAM.ICM registry

        Exclusion Criteria:

          -  Life-expectancy is less than 3 months

          -  Already implanted with BIOMONITOR
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romain ESCHALIER, Pr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Gabriel Montpied</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sabrina Hoche, Dr.</last_name>
    <phone>+49 (0) 30 68905-1337</phone>
    <email>france-biostream.icm@biotronik.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jens Buttgereit, Dr.</last_name>
    <phone>+49 30 68905 1267</phone>
    <email>biomonitor-registry@biotronik.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Gabriel Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <state>Caen</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH Villefranche Sur Saone</name>
      <address>
        <city>Gleizé</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Le Vavasseur, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU de Tours, Hopital Trousseau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand Pierre, Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>December 12, 2019</study_first_submitted>
  <study_first_submitted_qc>December 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2019</study_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syncope</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

